Streetbeat News

Revenues

LLY

Eli Lilly (NYSE:LLY) is evaluated against its peers in the Pharmaceuticals industry. The company shows high valuation metrics (PE, PB, PS ratios) compared to industry averages, indicating potential overvaluation. However, it has strong ROE and revenue growth, suggesting profitability and future prospects. Concerns arise from lower EBITDA and gross profit, indicating potential operational inefficiencies.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 3:00 pm

TW

Tradeweb Markets shares are experiencing an uptick following the announcement of a year-over-year increase in average daily volume for September and Q3.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:56 pm

STLA

Stellantis, the parent company of Jeep and Ram, is implementing strict cost-cutting measures to conserve cash and reverse declining profits. The company's CFO has revived the 'doghouse' approach to limit external spending.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:50 pm

SNY

Sanofi has sold the global rights to its rare autoimmune drug Enjaymo to Recordati for $825 million upfront, with potential milestone payments of $250 million. Enjaymo, approved by the FDA in 2022, is expected to see significant revenue growth. The deal is set to close by the end of 2024.

Portfolio Pulse from Vandana Singh

October 04, 2024 | 2:42 pm

TMUS

VZ

BakedBot AI, founded by Martez Knox, is revolutionizing the cannabis industry with AI-driven bots that enhance customer experiences and streamline dispensary operations. The company addresses marketing challenges by using AI to improve customer engagement and optimize business processes. BakedBot AI's tools help dispensaries personalize customer interactions, optimize pricing, and manage inventory effectively.

Portfolio Pulse from Nicolás Jose Rodriguez

October 04, 2024 | 2:27 pm

SPY

In a Bloomberg TV interview, Fed's Goolsbee stated that a broad set of data indicates the labor market is cooling. He also mentioned that if productivity continues to boom, it could imply higher growth and a higher neutral rate.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:15 pm

SPY

Federal Reserve's Goolsbee praises the latest jobs report as 'superb' and highlights the end of the port strike as positive news for the US economy. He cautions against overreacting to a single data point.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:05 pm

LEVI

M

Levi Strauss & Co (NYSE:LEVI) reported a mixed quarterly performance with a 5% sales growth but flat overall revenue. The company is considering selling its Dockers brand due to declining sales. Levi's direct selling strategy, aided by lower cotton costs, improved its gross margin. Despite missing revenue estimates, Levi reaffirmed its full-year earnings guidance.

Portfolio Pulse from Upwallstreet

October 04, 2024 | 2:04 pm

TBRG

TruBridge (NASDAQ:TBRG) has received mixed analyst ratings, with all five analysts being somewhat bullish. The average 12-month price target has increased by 4.69% to $13.4. TruBridge shows positive revenue growth but faces challenges with a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 2:01 pm

HROW

Harrow (NASDAQ:HROW) has received varied analyst ratings over the past three months, with a shift towards bullish sentiment. Analysts have raised their price targets, with the current average target at $52.5, up 36.36% from the previous $38.50. Harrow, an eyecare pharmaceutical company, has shown strong revenue growth but faces challenges with its ROE and ROA.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 2:01 pm